125 related articles for article (PubMed ID: 37028107)
1. A review on the role of NCK1 Antisense RNA 1 (NCK1-AS1) in diverse disorders.
Taheri M; Askari A; Behzad Moghadam K; Hussen BM; Ghafouri-Fard S; Kiani A
Pathol Res Pract; 2023 May; 245():154451. PubMed ID: 37028107
[TBL] [Abstract][Full Text] [Related]
2. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S
Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372
[TBL] [Abstract][Full Text] [Related]
3. NCK1-AS1 enhances glioma cell proliferation, radioresistance and chemoresistance via miR-22-3p/IGF1R ceRNA pathway.
Wang B; Wang K; Jin T; Xu Q; He Y; Cui B; Wang Y
Biomed Pharmacother; 2020 Sep; 129():110395. PubMed ID: 32887025
[TBL] [Abstract][Full Text] [Related]
4. LncRNA NCK1-AS1 exerts oncogenic property in gastric cancer by targeting the miR-22-3p/BCL9 axis to activate the Wnt/β-catenin signaling.
Guan B; Ma J; Yang Z; Yu F; Yao J
Environ Toxicol; 2021 Aug; 36(8):1640-1653. PubMed ID: 33974352
[TBL] [Abstract][Full Text] [Related]
5. Suppression of long noncoding RNA NCK1-AS1 increases chemosensitivity to cisplatin in cervical cancer.
Zhang WY; Liu YJ; He Y; Chen P
J Cell Physiol; 2019 Apr; 234(4):4302-4313. PubMed ID: 30221354
[TBL] [Abstract][Full Text] [Related]
6. LncRNA NCK1-AS1 Aggravates Hepatocellular Carcinoma by the miR-22-3p/YARS Axis to Activate PI3K/AKT Signaling.
Zhou W; Wang J; Zhang J; Wang Y; Jiang L; Guo T; Luo B; Xu Q; Huang Y
J Gastrointestin Liver Dis; 2022 Mar; 31(1):48-59. PubMed ID: 35306563
[TBL] [Abstract][Full Text] [Related]
7. NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/
Chen M; Cheng Y; Yuan Z; Wang F; Yang L; Zhao H
Cancer Biother Radiopharm; 2020 Mar; 35(2):101-108. PubMed ID: 31750728
[No Abstract] [Full Text] [Related]
8. NCK1-AS1 promotes the proliferation, migration, invasion, and EMT of non-small cell lung cancer by regulating the miR-361-5p/ADAM10 axis.
Wu B; Wang Z; Xu H; Chu X; Jiang Q
Histol Histopathol; 2023 Dec; 38(12):1453-1464. PubMed ID: 36912070
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA NCK1-AS1 promotes the tumorigenesis of glioma through sponging microRNA-138-2-3p and activating the TRIM24/Wnt/β-catenin axis.
Huang L; Li X; Ye H; Liu Y; Liang X; Yang C; Hua L; Yan Z; Zhang X
J Exp Clin Cancer Res; 2020 Apr; 39(1):63. PubMed ID: 32293515
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA NCK1-AS1 functions as a ceRNA to regulate cell viability and invasion in esophageal squamous cell carcinoma via microRNA-133b/ENPEP axis.
He XY; Wang XQ; Xiao QL; Liu D; Xu QR; Liu S
Cell Cycle; 2023 Mar; 22(5):596-609. PubMed ID: 36412985
[TBL] [Abstract][Full Text] [Related]
11. A review on the role of ZEB1-AS1 in human disorders.
Ghafouri-Fard S; Askari A; Behzad Moghadam K; Hussen BM; Taheri M; Samadian M
Pathol Res Pract; 2023 May; 245():154486. PubMed ID: 37120907
[TBL] [Abstract][Full Text] [Related]
12. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA HNF1A-AS1 promotes cell proliferation and invasion via regulating miR-17-5p in non-small cell lung cancer.
Zhang G; An X; Zhao H; Zhang Q; Zhao H
Biomed Pharmacother; 2018 Feb; 98():594-599. PubMed ID: 29289833
[TBL] [Abstract][Full Text] [Related]
14. LncRNA NCK1-AS1 promotes proliferation and induces cell cycle progression by crosstalk NCK1-AS1/miR-6857/CDK1 pathway.
Li H; Jia Y; Cheng J; Liu G; Song F
Cell Death Dis; 2018 Feb; 9(2):198. PubMed ID: 29416014
[TBL] [Abstract][Full Text] [Related]
15. LncRNA NCK1-AS1 Promotes Malignant Cellular Phenotypes of Laryngeal Squamous Cell Carcinoma via miR-137/NCK1 Axis.
Wan L; Gu D; Jin X
Mol Biotechnol; 2022 Aug; 64(8):888-901. PubMed ID: 35218517
[TBL] [Abstract][Full Text] [Related]
16. microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer.
Li P; Xing W; Xu J; Yuan D; Liang G; Liu B; Ma H
Stem Cell Res Ther; 2019 May; 10(1):144. PubMed ID: 31113460
[TBL] [Abstract][Full Text] [Related]
17. NCK1-AS1 promotes the progression of melanoma by accelerating cell proliferation and migration via targeting miR-526b-5p/ADAM15 axis.
Lin Q; Jia Y; Zhang D; Jin H
Cancer Cell Int; 2021 Jul; 21(1):367. PubMed ID: 34247598
[TBL] [Abstract][Full Text] [Related]
18. Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis.
Cui F; Luo P; Bai Y; Meng J
Technol Cancer Res Treat; 2021; 20():1533033821990007. PubMed ID: 33550957
[TBL] [Abstract][Full Text] [Related]
19. lncRNA HNF1A-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6.
Liu L; Chen Y; Li Q; Duan P
J Cell Biochem; 2019 Nov; 120(11):18736-18750. PubMed ID: 31243821
[TBL] [Abstract][Full Text] [Related]
20. LncRNA TMPO-AS1 facilitates the proliferation and metastasis of NSCLC cells by up-regulating ERBB2 via sponging miR-204-3p.
Yu X; Lin Q; Liu F; Yang F; Mao J; Chen X
Int J Immunopathol Pharmacol; 2020; 34():2058738420958947. PubMed ID: 32969763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
